我院在执行2012版《国家基本药物目录》中出现的问题和困惑

发布时间：2018-08-19 11:16

【摘要】：目的:为促进我国国家基本药物制度的全面实施和完善提供参考。方法:通过医院信息系统(HIS)收集我院2013年全年的药品品种、用药金额等信息并进行统计分析。结果:按2012版《国家基本药物目录》(下简称《目录》)统计,我院基本药物品种配备率和销售额占比均较按2009版《目录》统计明显下降;眼科专科用药基本药物采购率达80%,但眼科专科用药销售额中基本药物占比仅为4.13%,销售额居前10位的眼科专科用药中仅左氧氟沙星滴眼液在《目录》内;降眼压类药中销售份额最大的前列腺素类似物在《目录》中未收载。结论:《目录》中收载的眼科等专科用药品种少、品规局限,部分指南或共识推荐的品种未收录,难以满足医院专科用药的需求。因此,在今后修订《目录》时,应考虑适当增加专科用药品种或品规,以更好地满足临床药物需求。
[Abstract]:OBJECTIVE: To provide references for promoting the implementation and perfection of the national essential drug system in China. METHODS: The information of drug varieties and drug consumption amount in our hospital in 2013 were collected and statistically analyzed by the Hospital Information System (HIS). Preparedness rate and sales share were significantly lower than those of 2009 Edition < catalogue > statistics; the purchase rate of essential drugs for ophthalmic specialty drugs was 80%, but the sales of essential drugs for ophthalmic specialty drugs accounted for only 4.13%. Among the top 10 ophthalmic specialty drugs in sales, only levofloxacin eye drops had the largest sales share in < catalogue >. Conclusion: There are few kinds of special ophthalmic medicines in Catalogue, and some of them are not included in the catalogue, so it is difficult to meet the demand of special drug use in hospitals. To meet the needs of clinical drugs.
【作者单位】：郑州市第二人民医院药务科;
【分类号】：R95

【参考文献】